These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30582902)

  • 21. False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences.
    Piketty ML; Polak M; Flechtner I; Gonzales-Briceño L; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):780-788. PubMed ID: 27732554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotin immunoassay interference: A UK-based prevalence study.
    Sanders A; Gama R; Ashby H; Mohammed P
    Ann Clin Biochem; 2021 Jan; 58(1):66-69. PubMed ID: 32936669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fake news? Biotin interference in thyroid immunoassays.
    Koehler VF; Mann U; Nassour A; Mann WA
    Clin Chim Acta; 2018 Sep; 484():320-322. PubMed ID: 29856977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The biotin interference within interference suppressed immunoassays.
    Kabiri P; Weiskirchen R; van Helden J
    J Clin Lab Anal; 2021 Sep; 35(9):e23940. PubMed ID: 34346119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotin Interference in Clinical Immunoassays: A Cause for Concern.
    Holmes EW; Samarasinghe S; Emanuele MA; Meah F
    Arch Pathol Lab Med; 2017 Nov; 141(11):1459-1460. PubMed ID: 29072950
    [No Abstract]   [Full Text] [Related]  

  • 26. An Analysis of the Biotin-(Strept)avidin System in Immunoassays: Interference and Mitigation Strategies.
    Balzer AHA; Whitehurst CB
    Curr Issues Mol Biol; 2023 Oct; 45(11):8733-8754. PubMed ID: 37998726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature.
    Elston MS; Sehgal S; Du Toit S; Yarndley T; Conaglen JV
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3251-5. PubMed ID: 27362288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey-based study of physician practices regarding biotin supplementation.
    Waqas B; Wu A; Yim E; Lipner SR
    J Dermatolog Treat; 2022 Feb; 33(1):573-574. PubMed ID: 32419559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays.
    Trambas C; Lu Z; Yen T; Sikaris K
    Ann Clin Biochem; 2018 Mar; 55(2):205-215. PubMed ID: 28875734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference From High-Dose Biotin Intake in Immunoassays for Potentially Time-Critical Analytes by Roche.
    Mrosewski I; Urbank M; Stauch T; Switkowski R
    Arch Pathol Lab Med; 2020 Sep; 144(9):1108-1117. PubMed ID: 31944861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference.
    Piketty ML; Prie D; Sedel F; Bernard D; Hercend C; Chanson P; Souberbielle JC
    Clin Chem Lab Med; 2017 May; 55(6):817-825. PubMed ID: 28222020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotin interference in immunoassay: a review for the laboratory scientist.
    Avery G
    Ann Clin Biochem; 2019 Jul; 56(4):424-430. PubMed ID: 31023057
    [No Abstract]   [Full Text] [Related]  

  • 33. Suspected Testosterone-Producing Tumor in a Patient Taking Biotin Supplements.
    Stieglitz HM; Korpi-Steiner N; Katzman B; Mersereau JE; Styner M
    J Endocr Soc; 2018 Jun; 2(6):563-569. PubMed ID: 29942920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biotin Interference in Susceptible CanAg Ca242 Immunoassays and Elimination Method.
    Huang H; Lin H; Huang L; Li Y; Li G; Huang J; Luo Y; Ke P
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotin interference: Underrecognized patient safety risk in laboratory testing.
    Gifford JL; Sadrzadeh SMH; Naugler C
    Can Fam Physician; 2018 May; 64(5):370. PubMed ID: 29760259
    [No Abstract]   [Full Text] [Related]  

  • 36. Sense and nonsense concerning biotin interference in laboratory tests.
    Moerman A; Delanghe JR
    Acta Clin Belg; 2022 Feb; 77(1):204-210. PubMed ID: 32567529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department.
    Katzman BM; Lueke AJ; Donato LJ; Jaffe AS; Baumann NA
    Clin Biochem; 2018 Sep; 60():11-16. PubMed ID: 30036510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing.
    Katzman BM; Hain EA; Donato LJ; Baumann NA
    J Appl Lab Med; 2021 Jul; 6(4):992-997. PubMed ID: 33907809
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Dasgupta A; Khalil S; Paddock T; Wahed A
    Ann Clin Lab Sci; 2022 Jan; 52(1):161-163. PubMed ID: 35181630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases].
    Ranaivosoa MK; Ganel S; Agin A; Romain S; Parent X; Reix N
    Nephrol Ther; 2017 Dec; 13(7):553-558. PubMed ID: 29133077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.